LMAT Q3'26 Earnings: EPS estimate is 0.69 USD

What happened

LeMaitre Vascular is scheduled to report Q3'26 results on November 4 after the market closes, with disclosure expected at 4:05 p.m. ET. The supplied estimates are revenue of $67.39 million and earnings per share, or profit attributable to each share, of $0.69.

Confirmed

Global impact / market context

The results will show whether sales and profit per share met the supplied estimates. A shortfall could raise questions about the company’s ability to generate revenue and profit; a beat could support confidence in its operating performance, although the article gives no forecast for investor reaction.

Analyst inference

LeMaitre Vascular’s scheduled results put attention on whether reported revenue and earnings per share match the estimates. Revenue below its estimate in the latest reported quarter could make the upcoming revenue comparison especially relevant, while an earnings-per-share miss could weigh on expectations for the company’s reported performance.

Analyst inference

What to watch

1. Check the announced Q3'26 revenue against the $67.39 million estimate; the comparison will show whether sales were higher or lower than the benchmark. Confirmed
2. Compare reported earnings per share with $0.69, the estimate for profit attributable to each share, to see whether results beat or missed expectations. Confirmed
3. Look for any explanation of differences from estimates: sustained sales weakness could constrain revenue growth, while stronger results could reinforce confidence in the company’s profit generation. Analyst inference

Evidence

• Original source link unavailable